About

Anshul Gupte, PhD, RAC-Drugs, joined PCI in March 2024 as Vice-President, Pharmaceutical Development. Dr Gupte has over 16 years of experience in concept, pharmaceutical development and commercialisation of drug products. He has experience in working on broad range of dosage forms, including solid orals, liquids, sterile and topicals, and has contributed to several branded and generic regulatory submissions for the US and worldwide markets.

Dr Gupte previously served as Senior Director Pharmaceutical Development and Scientific Affairs at Catalent and Senior Director, Scientific and Technical Affairs at Catalent Pharma from 2022 to 2024.
Dr Gupte previously held several positions at Metrics Contract Services including Senior Director, Scientific and Technical Affairs, Senior Director, Drug Product Development, Director and Associate Director of Pharmaceutical Development. Additionally, Dr Gupte was based in Australia for four years and served as Head of Formulation at Mayne Pharma and led development activities for complex generics.